Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sophia Genetics Sa (SOPH) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sophia Genetics Sa. Table 2 shows the detailed insider transactions. This company's CIK number is 1840706.
Total stock buying since 2026: $0.
Total stock sales since 2026: $578,468.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 120,701 | $578,468 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-04 | 0 | $0 | 111,942 | $536,601 | 0 | $0 |
| 2026-03 | 0 | $0 | 8,759 | $41,867 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-13 | Menu Philippe (Chief Medical Officer) | Sale | 4,400 | 4.76 | 20,961 |
| 2026-04-13 | Camblong Jurgi (Chief Executive Officer) | Sale | 4,399 | 4.76 | 20,956 |
| 2026-04-13 | Xu Zhenyu (Chief Scientific Officer) | Sale | 4,414 | 4.76 | 21,028 |
| 2026-04-13 | Muken Ross (President) | Sale | 4,442 | 4.76 | 21,166 |
| 2026-04-10 | Menu Philippe (Chief Medical Officer) | Sale | 3,725 | 4.68 | 17,440 |
| 2026-04-10 | Camblong Jurgi (Chief Executive Officer) | Sale | 12,232 | 4.72 | 57,710 |
| 2026-04-10 | Van Well Daan (Chief Legal Officer) | Sale | 2,400 | 4.67 | 11,200 |
| 2026-04-10 | Xu Zhenyu (Chief Scientific Officer) | Sale | 3,706 | 4.68 | 17,347 |
| 2026-04-10 | Muken Ross (President) | Sale | 3,687 | 4.69 | 17,277 |
| 2026-04-09 | Menu Philippe (Chief Medical Officer) | Sale | 1,931 | 4.74 | 9,151 |
| 2026-04-09 | Camblong Jurgi (Chief Executive Officer) | Sale | 1,950 | 4.74 | 9,243 |
| 2026-04-09 | Van Well Daan (Chief Legal Officer) | Sale | 1,988 | 4.74 | 9,425 |
| 2026-04-09 | Xu Zhenyu (Chief Scientific Officer) | Sale | 1,936 | 4.74 | 9,176 |
| 2026-04-09 | Muken Ross (President) | Sale | 1,950 | 4.74 | 9,239 |
| 2026-04-08 | Menu Philippe (Chief Medical Officer) | Sale | 2,800 | 4.84 | 13,543 |
| 2026-04-08 | Valente Manuela (Chief People Officer) | Sale | 3,824 | 4.85 | 18,542 |
| 2026-04-08 | Camblong Jurgi (Chief Executive Officer) | Sale | 2,800 | 4.84 | 13,552 |
| 2026-04-08 | Van Well Daan (Chief Legal Officer) | Sale | 2,861 | 4.84 | 13,861 |
| 2026-04-08 | Xu Zhenyu (Chief Scientific Officer) | Sale | 2,800 | 4.84 | 13,549 |
| 2026-04-08 | Muken Ross (President) | Sale | 2,786 | 4.84 | 13,487 |
| 2026-04-08 | Cardoza George (Chief Financial Officer) | Sale | 1,403 | 4.85 | 6,800 |
| 2026-04-07 | Verma Abhimanyu (Chief Technology Officer) | Sale | 1,030 | 4.87 | 5,016 |
| 2026-04-07 | Menu Philippe (Chief Medical Officer) | Sale | 2,400 | 4.87 | 11,676 |
| 2026-04-07 | Valente Manuela (Chief People Officer) | Sale | 2,376 | 4.87 | 11,566 |
| 2026-04-07 | Camblong Jurgi (Chief Executive Officer) | Sale | 2,500 | 4.86 | 12,155 |
| 2026-04-07 | Van Well Daan (Chief Legal Officer) | Sale | 2,400 | 4.87 | 11,680 |
| 2026-04-07 | Xu Zhenyu (Chief Scientific Officer) | Sale | 2,400 | 4.87 | 11,678 |
| 2026-04-07 | Muken Ross (President) | Sale | 2,424 | 4.87 | 11,802 |
| 2026-04-07 | Cardoza George (Chief Financial Officer) | Sale | 2,413 | 4.88 | 11,768 |
| 2026-04-06 | Puylaert Kevin (Chief Sales Officer) | Sale | 624 | 4.85 | 3,026 |
| 2026-04-06 | Verma Abhimanyu (Chief Technology Officer) | Sale | 2,519 | 4.86 | 12,239 |
| 2026-04-06 | Menu Philippe (Chief Medical Officer) | Sale | 2,700 | 4.85 | 13,097 |
| 2026-04-06 | Valente Manuela (Chief People Officer) | Sale | 2,597 | 4.84 | 12,582 |
| 2026-04-06 | Camblong Jurgi (Chief Executive Officer) | Sale | 2,600 | 4.85 | 12,615 |
| 2026-04-06 | Van Well Daan (Chief Legal Officer) | Sale | 2,705 | 4.86 | 13,135 |
| 2026-04-06 | Xu Zhenyu (Chief Scientific Officer) | Sale | 2,700 | 4.85 | 13,100 |
| 2026-04-06 | Muken Ross (President) | Sale | 2,600 | 4.85 | 12,602 |
| 2026-04-06 | Cardoza George (Chief Financial Officer) | Sale | 2,520 | 4.85 | 12,211 |
| 2026-03-31 | Puylaert Kevin (Chief Sales Officer) | Sale | 3 | 4.71 | 14 |
| 2026-03-19 | Puylaert Kevin (Chief Sales Officer) | Sale | 33 | 4.76 | 157 |
| 2026-03-19 | Menu Philippe (Chief Medical Officer) | Sale | 608 | 4.79 | 2,912 |
| 2026-03-19 | Valente Manuela (Chief People Officer) | Sale | 380 | 4.79 | 1,818 |
| 2026-03-19 | Camblong Jurgi (Chief Executive Officer) | Sale | 4,486 | 4.77 | 21,411 |
| 2026-03-19 | Van Well Daan (Chief Legal Officer) | Sale | 684 | 4.79 | 3,274 |
| 2026-03-19 | Xu Zhenyu (Chief Scientific Officer) | Sale | 608 | 4.78 | 2,906 |
| 2026-03-19 | Muken Ross (President) | Sale | 1,183 | 4.79 | 5,671 |
| 2026-03-19 | Cardoza George (Chief Financial Officer) | Sale | 774 | 4.79 | 3,704 |
Insider trading activities including stock purchases, stock sales, and option exercises of SOPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sophia Genetics Sa (symbol SOPH, CIK number 1840706) see the Securities and Exchange Commission (SEC) website.